51
TITLE: Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma
AUTHORS: Catarina Dias; David A Isenberg;
PUBLISHED: 2011, SOURCE: NATURE REVIEWS RHEUMATOLOGY, VOLUME: 7, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
53
TITLE: Working through the recession
AUTHORS: Lynne Shand; Sara Cortes; David Isenberg;
PUBLISHED: 2010, SOURCE: RHEUMATOLOGY, VOLUME: 49, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
54
TITLE: An analysis of joint replacement in patients with systemic lupus erythematosus  Full Text
AUTHORS: Mourao, AF; Amaral, M; Caetano Lopes, J; Isenberg, D;
PUBLISHED: 2009, SOURCE: LUPUS, VOLUME: 18, ISSUE: 14
INDEXED IN: Scopus WOS CrossRef
55
TITLE: OPINION B-cell-depletion therapy in SLE-what are the current prospects for its acceptance?
AUTHORS: Catarina Favas; David A Isenberg;
PUBLISHED: 2009, SOURCE: NATURE REVIEWS RHEUMATOLOGY, VOLUME: 5, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef
57
TITLE: Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus
AUTHORS: Batuca, JR ; Ames, PRJ; Isenberg, DA; Delgado D Alves ;
PUBLISHED: 2007, SOURCE: 5th International Congress on Autoimmunity in AUTOIMMUNITY, PT D: AUTOIMMUNE DISEASE, ANNUS MIRABILIS, VOLUME: 1108
INDEXED IN: Scopus WOS
59
TITLE: Antibodies towards high density lipoproteins components in patients with systemic lupus erythematosus inhibit paraoxonase activity.  Full Text
AUTHORS: Joana Batuca; Giuseppe Manco; David A Isenberg; Jose Delgado Alves;
PUBLISHED: 2006, SOURCE: 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals in ARTHRITIS AND RHEUMATISM, VOLUME: 54, ISSUE: 9
INDEXED IN: WOS
Page 6 of 7. Total results: 65.